{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:50:05Z","timestamp":1769147405244,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"DOI":"10.1007\/s11894-025-01027-w","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:11:35Z","timestamp":1769091095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors and Outcomes of Immunoglobulin A Vasculitis in Patients with Inflammatory Bowel Disease and vice versa: A Systematic Review of the current literature"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7845-1327","authenticated-orcid":false,"given":"Samer A.","family":"Al-Shbailat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4130-1237","authenticated-orcid":false,"given":"Shahd","family":"Alqato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0615-7369","authenticated-orcid":false,"given":"Asem Y.","family":"Alkhalaileh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-2064","authenticated-orcid":false,"given":"Rand","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-3159","authenticated-orcid":false,"given":"Sadeen","family":"Zein Eddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0344-7859","authenticated-orcid":false,"given":"Alyaman","family":"Karajeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9327-6162","authenticated-orcid":false,"given":"Raghad G.","family":"Al-Shbeilat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6384-4678","authenticated-orcid":false,"given":"Rama","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-3562","authenticated-orcid":false,"given":"Hamzeh","family":"Hatamleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-4664","authenticated-orcid":false,"given":"Jaber H.","family":"Jaradat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Alsagarat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7464-912X","authenticated-orcid":false,"given":"Laila K.","family":"Asfour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"1027_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS. Inflammatory Bowel Disease. Annu Rev Immunol. 2010;28:573\u2013621.","journal-title":"Annu Rev Immunol"},{"key":"1027_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144\u2013164K.","journal-title":"J Crohns Colitis."},{"key":"1027_CR3","volume-title":"StatPearls","author":"P Roache-Robinson","year":"2025","unstructured":"Roache-Robinson P, Killeen RB, Hotwagner DT. IgA Vasculitis (Henoch-Sch\u00f6nlein Purpura). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. [cited 2025 Apr 13]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537252\/."},{"key":"1027_CR4","doi-asserted-by":"publisher","first-page":"771619","DOI":"10.3389\/fimmu.2021.771619","volume":"12","author":"Y Song","year":"2021","unstructured":"Song Y, Huang X, Yu G, Qiao J, Cheng J, Wu J, et al. Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021;12:771619.","journal-title":"Front Immunol"},{"key":"1027_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-016-0959-4","volume":"18","author":"A Ho\u010devar","year":"2016","unstructured":"Ho\u010devar A, Rotar Z, Jur\u010di\u0107 V, Pi\u017eem J, \u010cu\u010dnik S, Vizjak A, et al. IgA vasculitis in adults: the performance of the EULAR\/PRINTO\/PRES classification criteria in adults. Arthritis Res Ther. 2016;18:58.","journal-title":"Arthritis Res Ther"},{"key":"1027_CR6","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/rheumatology\/keab662","volume":"61","author":"C Rasmussen","year":"2022","unstructured":"Rasmussen C, Abitbol V, El Karoui K, Bourrier A, Paule R, Vuitton L, et al. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-\u03b1 blockers. Rheumatology. 2022;61:1957\u201365.","journal-title":"Rheumatology"},{"key":"1027_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","volume":"87","author":"O Sokumbi","year":"2012","unstructured":"Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis Associated With Tumor Necrosis Factor-\u03b1 Inhibitors. Mayo Clin Proc. 2012;87:739\u201345.","journal-title":"Mayo Clin Proc"},{"key":"1027_CR8","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","volume":"22","author":"KK Lau","year":"2007","unstructured":"Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura. Pediatr Nephrol. 2007;22:2067\u201372.","journal-title":"Pediatr Nephrol"},{"key":"1027_CR9","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/ndt\/gfae052","volume":"39","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, He H, Sun W, Wu J, Xiao Y, Peng Y, et al. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway. Nephrol Dial Transplant. 2024;39:1624\u201341.","journal-title":"Nephrol Dial Transplant"},{"key":"1027_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ckj\/sfac214","volume":"16","author":"Q Li","year":"2023","unstructured":"Li Q, Yuan X, Shi S, Liu L, Lv J, Zhu L, et al. Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis. Clin Kidney J. 2023;16:184\u201391.","journal-title":"Clin Kidney J"},{"key":"1027_CR11","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/rheumatology\/keab662","volume":"61","author":"C Rasmussen","year":"2022","unstructured":"Rasmussen C, Abitbol V, El Karoui K, Bourrier A, Paule R, Vuitton L, et al. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-\u03b1 blockers. Rheumatology. 2022;61:1957\u201365.","journal-title":"Rheumatology"},{"key":"1027_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/0-387-33778-4_10","volume":"579","author":"P Brandtzaeg","year":"2006","unstructured":"Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease. Adv Exp Med Biol. 2006;579:149\u201367.","journal-title":"Adv Exp Med Biol"},{"key":"1027_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.autrev.2017.11.024","volume":"17","author":"R L\u00f3pez-Mej\u00edas","year":"2018","unstructured":"L\u00f3pez-Mej\u00edas R, Casta\u00f1eda S, Genre F, Remuzgo-Mart\u00ednez S, Carmona FD, Llorca J, et al. Genetics of immunoglobulin-A vasculitis (Henoch-Sch\u00f6nlein purpura): An updated review. Autoimmun Rev. 2018;17:301\u201315.","journal-title":"Autoimmun Rev"},{"key":"1027_CR14","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s00467-021-04955-7","volume":"36","author":"M Koskela","year":"2021","unstructured":"Koskela M, Nihtil\u00e4 J, Ylinen E, Kolho KL, Nuutinen M, Ritari J, et al. HLA-DQ and HLA-DRB1 alleles associated with Henoch-Sch\u00f6nlein purpura nephritis in Finnish pediatric population: a genome-wide association study. Pediatr Nephrol. 2021;36:2311\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1027_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.dld.2023.08.044","volume":"56","author":"H Li","year":"2024","unstructured":"Li H, Xin Q, Hong L, Hu Y, Lin L, Guo M, et al. Mendelian randomization analysis reveals causality of inflammatory bowel disease on risks of Henoch-Sch\u00f6nlein purpura and immune thrombocytopenia. Dig Liver Dis. 2024;56:92\u20137. https:\/\/www.dldjournalonline.com\/article\/S1590-8658(23)00856-3\/fulltext#back-bib0021","journal-title":"Dig Liver Dis"},{"key":"1027_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","volume":"42","author":"MF Cusick","year":"2012","unstructured":"Cusick MF, Libbey JE, Fujinami RS. Molecular Mimicry as a Mechanism of Autoimmune Disease. Clin Rev Allergy Immunol. 2012;42:102\u201311.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1027_CR17","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.autrev.2020.102707","volume":"20","author":"C Rasmussen","year":"2021","unstructured":"Rasmussen C, Tisseyre M, Garon-Czmil J, Atzenhoffer M, Guillevin L, Salem JE, et al. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev. 2021;20:102707.","journal-title":"Autoimmun Rev"},{"key":"1027_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","volume":"9","author":"I Cleynen","year":"2012","unstructured":"Cleynen I, Vermeire S. Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol. 2012;9:496\u2013503.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1027_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4049\/jimmunol.1003964","volume":"188","author":"D Frasca","year":"2012","unstructured":"Frasca D, Romero M, Diaz A, Alter-Wolf S, Ratliff M, Landin AM, et al. A molecular mechanism for TNF-\u03b1-mediated down-regulation of B cell responses. J Immunol. 2012;188:279\u201386.","journal-title":"J Immunol"},{"key":"1027_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00312","author":"S Atiqi","year":"2020","unstructured":"Atiqi S, Hooijberg F, Loeff FC, Rispens T, Wolbink GJ. Immunogenicity of TNF-inhibitors. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00312.","journal-title":"Front Immunol"},{"key":"1027_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1046\/j.1523-1755.2002.00161.x","volume":"61","author":"R Kettritz","year":"2002","unstructured":"Kettritz R, Scheumann J, Xu Y, Luft FC, Haller H. TNF-\u03b1\u2013accelerated apoptosis abrogates ANCA-mediated neutrophil respiratory burst by a caspase-dependent mechanism1. Kidney Int. 2002;61:502\u201315.","journal-title":"Kidney Int"},{"key":"1027_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1134\/S0022093021030017","volume":"57","author":"EM Noseykina","year":"2021","unstructured":"Noseykina EM, Schepetkin IA, Atochin DN. Molecular mechanisms for regulationof neutrophil apoptosis under normal and pathological conditions. J Evol Biochem Physiol. 2021;57:429\u201350.","journal-title":"J Evol Biochem Physiol"},{"key":"1027_CR23","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1027_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016;75:40\u20136.","journal-title":"J Clin Epidemiol"},{"key":"1027_CR25","unstructured":"Rayyan \u2013 Intelligent Systematic Review - Rayyan. 2021 [cited 2024 May 10]; https:\/\/www.rayyan.ai\/"},{"key":"1027_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/ecco-jcc\/jjz164","volume":"14","author":"M Condamina","year":"2020","unstructured":"Condamina M, Diaz E, Jamart C, Loget J, Durlach A, Salmon JH, et al. Severe Attack of Henoch-Sch\u00f6nlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn\u2019s Disease. J Crohns Colitis. 2020;14:538\u201342.","journal-title":"J Crohns Colitis"},{"key":"1027_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/BF01070796","volume":"20","author":"RM Craig","year":"1975","unstructured":"Craig RM, Ashman M, Feldman S, Hasegawa J, Dordal E. Ulcerative colitis and anaphylactoid purpura. Dig Dis Sci. 1975;20:487\u201393.","journal-title":"Dig Dis Sci"},{"key":"1027_CR28","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/s10620-023-07934-0","volume":"68","author":"K Darlington","year":"2023","unstructured":"Darlington K, Googe P, Vedak P, Jain A, Long MD, Barnes EL, et al. Lower extremity palpable purpura in a patient with quiescent inflammatory bowel disease. Dig Dis Sci. 2023;68:2861\u20135.","journal-title":"Dig Dis Sci"},{"key":"1027_CR29","doi-asserted-by":"publisher","first-page":"e01145","DOI":"10.14309\/crj.0000000000001145","volume":"10","author":"TS Desai","year":"2023","unstructured":"Desai TS, Jurencak R, Nair A, Carman N. Atypical Immunoglobulin A vasculitis in a pediatric patient with ulcerative colitis. ACG Case Rep J. 2023;10:e01145.","journal-title":"ACG Case Rep J"},{"key":"1027_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2018.03.048","volume":"155","author":"SL Gold","year":"2018","unstructured":"Gold SL, Magro C, Scherl E. A unique infusion reaction to vedolizumab in a patient with Crohn\u2019s disease. Gastroenterology. 2018;155:981\u20132.","journal-title":"Gastroenterology"},{"key":"1027_CR31","doi-asserted-by":"crossref","unstructured":"Hokama A, Sonosaki T, Zamami R, Aoyama H, Kinjo T, Fujita J. Crohn\u2019s disease complicated by IgA vasculitis during tumor necrosis factor-\u03b1 inhibitor therapy. Pol Arch Intern Med. 2019; http:\/\/pamw.pl\/en\/node\/4435","DOI":"10.20452\/pamw.4435"},{"key":"1027_CR32","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s12328-021-01456-w","volume":"14","author":"JG Hong","year":"2021","unstructured":"Hong JG, Levy J, Stokar E. Henoch-Sch\u00f6nlein purpura and crohn\u2019s disease: expanding the range of association in pediatric patients. Clin J Gastroenterol. 2021;14:1392\u20135.","journal-title":"Clin J Gastroenterol"},{"key":"1027_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s13730-022-00727-w","volume":"12","author":"C Ito","year":"2022","unstructured":"Ito C, Odajima K, Niimura Y, Fujii M, Sone M, Asakawa S, et al. IgA vasculitis with transient glomerular hematuria, diarrhea, and pericarditis following COVID-19 mRNA vaccination in a young patient with possible pre-existing ulcerative colitis. CEN Case Rep. 2022;12:84\u201390.","journal-title":"CEN Case Rep"},{"key":"1027_CR34","first-page":"1","volume":"2016","author":"JJ LaConti","year":"2016","unstructured":"LaConti JJ, Donet JA, Cho-Vega JH, Sussman DA, Ascherman D, Deshpande AR. Henoch-Sch\u00f6nlein purpura with adalimumab therapy for ulcerative colitis: a case report and review of the literature. Case Rep Rheumatol. 2016;2016:1\u20134.","journal-title":"Case Rep Rheumatol"},{"key":"1027_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.crohns.2012.02.019","volume":"6","author":"I Marques","year":"2012","unstructured":"Marques I, Lagos A, Reis J, Pinto A, Neves B. Reversible Henoch\u2013Sch\u00f6nlein purpura complicating adalimumab therapy. J Crohns Colitis. 2012;6:796\u20139.","journal-title":"J Crohns Colitis"},{"key":"1027_CR36","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMcpc1616397","volume":"376","author":"EM Miloslavsky","year":"2017","unstructured":"Miloslavsky EM, Stone JH, Moy AP. Case 14-2017: a 20-year-old man with pain and swelling of the left calf and a purpuric rash. N Engl J Med. 2017;376:1868\u201377.","journal-title":"N Engl J Med"},{"key":"1027_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12328-009-0062-3","volume":"2","author":"K Ogawa","year":"2009","unstructured":"Ogawa K, Matsumoto T, Yada S, Hirano A, Kumagae Y, Goto K, et al. A case of Crohn\u2019s disease associated with Takayasu\u2019s arteritis and Henoch-Sch\u00f6nlein purpura. Clin J Gastroenterol. 2009;2:166\u20139.","journal-title":"Clin J Gastroenterol"},{"key":"1027_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1684\/ejd.2017.2978","volume":"27","author":"M Ueno","year":"2017","unstructured":"Ueno M, Namiki T, Hanafusa T, Miura K, Yokozeki H. IgA-mediated leukaemic vasculitis in a patient with rapid progression of myelodysplastic syndrome to acute myeloid leukaemia. Eur J Dermatol. 2017;27:303\u20134.","journal-title":"Eur J Dermatol"},{"key":"1027_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4292\/wjgpt.v1.i5.119","volume":"1","author":"FZ Rahman","year":"2010","unstructured":"Rahman FZ. Henoch sch\u00f6nlein purpura complicating adalimumab therapy for Crohn\u2019s disease. WJGPT. 2010;1:119.","journal-title":"WJGPT"},{"key":"1027_CR40","doi-asserted-by":"crossref","unstructured":"Sequeira C, Santos I, Lopes S, Teixeira C, Mangualde J, Oliveira AP. Henoch-Sch\u00f6nlein purpura masquerading as Crohn\u2019s disease flare. Rev Esp Enferm Dig. 2022; [cited 2024 Jul 16];Available from: https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=765748233417277-190168238631","DOI":"10.17235\/reed.2022.9414\/2022"},{"key":"1027_CR41","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.3748\/wjg.v21.i19.6082","volume":"21","author":"Y Song","year":"2015","unstructured":"Song Y, Shi YH, He C, Liu CQ, Wang JS, Zhao YJ, et al. Severe Henoch-Sch\u00f6nlein purpura with infliximab for ulcerative colitis. WJG. 2015;21:6082\u20137.","journal-title":"WJG"},{"key":"1027_CR42","first-page":"110","volume":"87","author":"N Urganci","year":"2022","unstructured":"Urganci N, Sakar M, Yalc\u00edn O, Kalyoncu D. Henoch-Sch\u00f6nlein purpura induced by infliximab for Crohn\u2019s disease: a case report and literature review. Rev Gastroenterol Mex (Engl Ed). 2022;87:110\u20132.","journal-title":"Rev Gastroenterol Mex (Engl. Ed.)"},{"key":"1027_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12328-020-01280-8","volume":"14","author":"J Urushikubo","year":"2021","unstructured":"Urushikubo J, Yanai S, Nakamura S, Toya Y, Asakura K, Gonai T, et al. IgA vasculitis in a patient with ulcerative colitis under infliximab: drug-induced or genetic? Clin J Gastroenterol. 2021;14:198\u2013203.","journal-title":"Clin J Gastroenterol"},{"key":"1027_CR44","first-page":"S12","volume":"114","author":"M Keeley","year":"2019","unstructured":"Keeley M, Cloney D, Kammeraad C. P046 a case of Henoch-Schonlein purpura during infliximab treatment for ulcerative colitis. Am J Gastroenterol. 2019;114:S12\u2013S12.","journal-title":"Am J Gastroenterol"},{"key":"1027_CR45","first-page":"S25","volume":"114","author":"M Anshu","year":"2019","unstructured":"Anshu M, Mohammad Y, Ian K, Christina L. P094 Henoch\u2013Schonlein purpura and inflammatory bowel disease. Am J Gastroenterol. 2019;114:S25\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1027_CR46","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/codi.12221","volume":"15","author":"A Tursi","year":"2013","unstructured":"Tursi A, Inchingolo CD. Ulcerative colitis in Henoch\u2013Sch\u00f6nlein purpura: which came first, the chicken or the egg? Colorectal Dis. 2013;15:762\u20133.","journal-title":"Colorectal Dis"},{"key":"1027_CR47","first-page":"173","volume":"31","author":"FT Saulsbury","year":"2000","unstructured":"Saulsbury FT, Hart MH. Crohn\u2019s disease presenting with Henoch-Sch??nlein purpura. J Pediatr Gastroenterol Nutr. 2000;31:173\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1027_CR48","volume":"3","author":"G Pomeranz","year":"2015","unstructured":"Pomeranz G, Zehavi T, Uziel Y, Pomeranz A, Korzets Z. Henoch\u2013Schonlein purpura antecedent to Crohn\u2019s disease. SAGE Open Med Case Rep. 2015;3:2050313X1560429.","journal-title":"SAGE Open Med Case Rep"},{"key":"1027_CR49","first-page":"147","volume":"27","author":"S Carella","year":"2013","unstructured":"Carella S, Maruccia M, Fino P, Onesti MG. An atypical case of Henoch-Shonlein purpura in a young patient: treatment of the skin lesions with hyaluronic acid-based dressings. In Vivo. 2013;27:147\u201351.","journal-title":"In Vivo"},{"key":"1027_CR50","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.3748\/wjg.v21.i19.6082","volume":"21","author":"Y Song","year":"2015","unstructured":"Song Y, Shi YH, He C, Liu CQ, Wang JS, Zhao YJ, et al. Severe Henoch-Sch\u00f6nlein purpura with infliximab for ulcerative colitis. WJG. 2015;21:6082\u20137.","journal-title":"WJG"},{"key":"1027_CR51","doi-asserted-by":"publisher","first-page":"e1074","DOI":"10.1097\/MEG.0000000000002046","volume":"33","author":"X Li","year":"2021","unstructured":"Li X, Wang Y, Ge T, Xiao Y, Zhang T. Henoch-Sch\u00f6nlein purpura associated with infliximab therapy for pediatric Crohn\u2019s disease. Eur J Gastroenterol Hepatol. 2021;33:e1074\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"1027_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/RHU.0b013e31819bca9e","volume":"15","author":"S Nobile","year":"2009","unstructured":"Nobile S, Catassi C, Felici L. Herpes zoster infection followed by Henoch-Sch\u00f6nlein purpura in a girl receiving infliximab for ulcerative colitis. JCR: Journal of Clinical Rheumatology. 2009;15:101.","journal-title":"JCR: Journal of Clinical Rheumatology"},{"key":"1027_CR53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/MPG.0b013e3181e5e198","volume":"51","author":"S Pastore","year":"2010","unstructured":"Pastore S, Londero M, Gortani G, Abate MV, Marchetti F, Di Leo G, et al. Infliximab-related vasculitis in patients affected by ulcerative colitis. J Pediatr Gastroenterol Nutr. 2010;51:226\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1027_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/03009742.2020.1732460","volume":"50","author":"M Villatoro-Villar","year":"2021","unstructured":"Villatoro-Villar M, Crowson C, Warrington K, Makol A, Koster M. Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study. Scand J Rheumatol. 2021;50:40\u20137.","journal-title":"Scand J Rheumatol"},{"key":"1027_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/annrheumdis-2021-221326","volume":"81","author":"C Cook","year":"2022","unstructured":"Cook C, Patel NJ, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann Rheum Dis. 2022;81:289\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1027_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00403-025-03965-x","volume":"317","author":"L Yan","year":"2025","unstructured":"Yan L, Shen J, Liu L, Yang M, Wang S. IgA vasculitis induced by tumor necrosis factor-\u03b1 antagonists: clinical features, diagnosis and management. Arch Dermatol Res. 2025;317:445.","journal-title":"Arch Dermatol Res"},{"key":"1027_CR57","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","volume":"13","author":"E Pillebout","year":"2002","unstructured":"Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-sch\u00f6nlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13:1271\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1027_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.921864","author":"L Xu","year":"2022","unstructured":"Xu L, Li Y, Wu X. IgA vasculitis update: epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.921864.","journal-title":"Front Immunol"},{"key":"1027_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211024828","volume":"13","author":"M Sestan","year":"2021","unstructured":"Sestan M, Kifer N, Frkovic M, Sapina M, Srsen S, Batnozic Varga M, et al. Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis. Ther Adv Musculoskelet Dis. 2021;13:1759720X211024828.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1027_CR60","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1111\/jgh.14751","volume":"34","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang J, Pekow J, Dalal S, Cohen RD, Ollech J, et al. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019;34:2090\u20135.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01027-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-01027-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01027-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:05:42Z","timestamp":1769094342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-01027-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-01027-w","relation":{},"ISSN":["1534-312X"],"issn-type":[{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}